(Q27332349)

English

BOB CAT: A Large-Scale Review and Delphi Consensus for Management of Barrett's Esophagus With No Dysplasia, Indefinite for, or Low-Grade Dysplasia

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

25 June 2017

1 reference

Europe PubMed Central

BOB CAT: A Large-Scale Review and Delphi Consensus for Management of Barrett's Esophagus With No Dysplasia, Indefinite for, or Low-Grade Dysplasia (English)

1 reference

Europe PubMed Central

25 June 2017

Barrett's esophagus

1 reference

based on heuristic

inferred from title

corrigendum / erratum

Erratum: Addendum: BOB CAT: A Large-Scale Review and Delphi Consensus for Management of Barrett’s Esophagus With No Dysplasia, Indefinite for, or Low-Grade Dysplasia

1 reference

10.1038/AJG.2015.151

12 July 2019

http://api.crossref.org/works?select=update-to&filter=doi:10.1038/AJG.2015.151

2

object named as

Paul Moayyedi

1 reference

Europe PubMed Central

25 June 2017

10

object named as

John Inadomi

1 reference

Europe PubMed Central

25 June 2017

26

object named as

Raf Bisschops

1 reference

Europe PubMed Central

25 June 2017

object named as

Cathy Bennett

1

0 references

object named as

Gary Falk

6

0 references

object named as

Jan Tack

40

0 references

Janusz A. Jankowski

object named as

Janusz Jankowski

52

0 references

Peter Malfertheiner

48

object named as

Peter Malfertheiner

1 reference

Europe PubMed Central

25 June 2017

Bita Geramizadeh

27

object named as

Bita Geramizadeh

1 reference

Europe PubMed Central

25 June 2017

Eamonn M M Quigley

15

object named as

Eamonn Quigley

1 reference

Europe PubMed Central

25 June 2017

Douglas A. Corley

3

object named as

Douglas A Corley

1 reference

Europe PubMed Central

25 June 2017

Peter D Siersema

39

object named as

Peter D Siersema

1 reference

Europe PubMed Central

25 June 2017

13

object named as

Robert Odze

1 reference

Europe PubMed Central

25 June 2017

author name string

John DeCaestecker

4

1 reference

Europe PubMed Central

25 June 2017

Yngve Falck-Ytter

5

1 reference

Europe PubMed Central

25 June 2017

Nimish Vakil

7

1 reference

Europe PubMed Central

25 June 2017

Scott Sanders

8

1 reference

Europe PubMed Central

25 June 2017

Michael Vieth

9

1 reference

Europe PubMed Central

25 June 2017

David Aldulaimi

11

1 reference

Europe PubMed Central

25 June 2017

Khek-Yu Ho

12

1 reference

Europe PubMed Central

25 June 2017

Stephen J Meltzer

14

1 reference

Europe PubMed Central

25 June 2017

Stuart Gittens

16

1 reference

Europe PubMed Central

25 June 2017

Peter Watson

17

1 reference

Europe PubMed Central

25 June 2017

Giovanni Zaninotto

18

1 reference

Europe PubMed Central

25 June 2017

Prasad G Iyer

19

1 reference

Europe PubMed Central

25 June 2017

Leo Alexandre

20

1 reference

Europe PubMed Central

25 June 2017

Yeng Ang

21

1 reference

Europe PubMed Central

25 June 2017

James Callaghan

22

1 reference

Europe PubMed Central

25 June 2017

Rebecca Harrison

23

1 reference

Europe PubMed Central

25 June 2017

Rajvinder Singh

24

1 reference

Europe PubMed Central

25 June 2017

Pradeep Bhandari

25

1 reference

Europe PubMed Central

25 June 2017

Philip Kaye

28

1 reference

Europe PubMed Central

25 June 2017

Sheila Krishnadath

29

1 reference

Europe PubMed Central

25 June 2017

M Brian Fennerty

30

1 reference

Europe PubMed Central

25 June 2017

Hendrik Manner

31

1 reference

Europe PubMed Central

25 June 2017

Katie S Nason

32

1 reference

Europe PubMed Central

25 June 2017

Oliver Pech

33

1 reference

Europe PubMed Central

25 June 2017

Vani Konda

34

1 reference

Europe PubMed Central

25 June 2017

Krish Ragunath

35

1 reference

Europe PubMed Central

25 June 2017

Imdadur Rahman

36

1 reference

Europe PubMed Central

25 June 2017

Yvonne Romero

37

1 reference

Europe PubMed Central

25 June 2017

Richard Sampliner

38

1 reference

Europe PubMed Central

25 June 2017

Tony C K Tham

41

1 reference

Europe PubMed Central

25 June 2017

Nigel Trudgill

42

1 reference

Europe PubMed Central

25 June 2017

David S Weinberg

43

1 reference

Europe PubMed Central

25 June 2017

Jean Wang

44

1 reference

Europe PubMed Central

25 June 2017

Kenneth Wang

45

1 reference

Europe PubMed Central

25 June 2017

Jennie Y Y Wong

46

1 reference

Europe PubMed Central

25 June 2017

Stephen Attwood

47

1 reference

Europe PubMed Central

25 June 2017

David MacDonald

49

1 reference

Europe PubMed Central

25 June 2017

Hugh Barr

50

1 reference

Europe PubMed Central

25 June 2017

Mark K Ferguson

51

1 reference

Europe PubMed Central

25 June 2017

BOB CAT Consortium

53

1 reference

Europe PubMed Central

25 June 2017

language of work or name

0 references

publication date

14 April 2015

1 reference

Europe PubMed Central

25 June 2017

The American Journal of Gastroenterology

1 reference

Europe PubMed Central

25 June 2017

110

1 reference

Europe PubMed Central

25 June 2017

662-82; quiz 683

1 reference

Europe PubMed Central

25 June 2017

5

1 reference

Europe PubMed Central

25 June 2017

Recent developments in esophageal adenocarcinoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4436697

21 March 2017

Surgery versus radical endotherapies for early cancer and high-grade dysplasia in Barrett's oesophagus

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4436697

21 March 2017

Durability of radiofrequency ablation in Barrett's esophagus with dysplasia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4436697

21 March 2017

The Vienna classification of gastrointestinal epithelial neoplasia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4436697

21 March 2017

Global cancer statistics, 2012

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4436697

21 March 2017

GRADE: an emerging consensus on rating quality of evidence and strength of recommendations

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4436697

21 March 2017

The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4436697

21 March 2017

Proton-pump inhibitor therapy and the development of dysplasia in patients with Barrett's oesophagus

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4436697

21 March 2017

Radiofrequency ablation in Barrett's esophagus with dysplasia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4436697

21 March 2017

Efficacy of medical therapy and antireflux surgery to prevent Barrett's metaplasia in patients with gastroesophageal reflux disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4436697

21 March 2017

GRADE guidelines: 1. Introduction-GRADE evidence profiles and summary of findings tables

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4436697

7 April 2017

Barrett's oesophagus patients with low-grade dysplasia can be accurately risk-stratified after histological review by an expert pathology panel

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4436697

28 September 2017

Definition of Barrett's esophagus dysplasia: are we speaking the same language?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4436697

28 September 2017

Meta-analysis of endoscopic therapy for low-grade dysplasia in Barrett's oesophagus.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4436697

28 September 2017

Detection and staging of esophageal cancers within Barrett's esophagus is improved by assessment in specialized Barrett's units

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4436697

28 September 2017

Radiofrequency ablation vs endoscopic surveillance for patients with Barrett esophagus and low-grade dysplasia: a randomized clinical trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4436697

28 September 2017

Use of proton pump inhibitors after antireflux surgery: a nationwide register-based follow-up study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4436697

28 September 2017

Acid-suppressive medications and risk of oesophageal adenocarcinoma in patients with Barrett's oesophagus: a systematic review and meta-analysis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4436697

28 September 2017

British Society of Gastroenterology guidelines on the diagnosis and management of Barrett's oesophagus

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4436697

28 September 2017

Barrett esophagus and risk of esophageal cancer: a clinical review

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4436697

28 September 2017

Central adiposity is associated with increased risk of esophageal inflammation, metaplasia, and adenocarcinoma: a systematic review and meta-analysis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4436697

28 September 2017

Impact of endoscopic surveillance on mortality from Barrett's esophagus-associated esophageal adenocarcinomas

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4436697

28 September 2017

Endoscopic mucosal resection results in change of histologic diagnosis in Barrett's esophagus patients with visible and flat neoplasia: a multicenter cohort study.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4436697

28 September 2017

Radiofrequency ablation and endoscopic mucosal resection for dysplastic barrett's esophagus and early esophageal adenocarcinoma: outcomes of the UK National Halo RFA Registry

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4436697

28 September 2017

Recurrence of esophageal intestinal metaplasia after endoscopic mucosal resection and radiofrequency ablation of Barrett's esophagus: results from a US Multicenter Consortium

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4436697

28 September 2017

Association between markers of obesity and progression from Barrett's esophagus to esophageal adenocarcinoma.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4436697

28 September 2017

Risk factors for esophageal adenocarcinoma after antireflux surgery

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4436697

28 September 2017

Effect of Barrett's esophagus surveillance on esophageal preservation, tumor stage, and survival with esophageal adenocarcinoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4436697

28 September 2017

The role of tobacco, alcohol, and obesity in neoplastic progression to esophageal adenocarcinoma: a prospective study of Barrett's esophagus

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4436697

28 September 2017

The cost effectiveness of radiofrequency ablation for Barrett's esophagus.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4436697

28 September 2017

Consensus statements for management of Barrett's dysplasia and early-stage esophageal adenocarcinoma, based on a Delphi process

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4436697

28 September 2017

Validation of the Prague C & M criteria for the endoscopic grading of Barrett's esophagus by gastroenterology trainees: a multicenter study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4436697

28 September 2017

Erosive reflux disease increases risk for esophageal adenocarcinoma, compared with nonerosive reflux

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4436697

28 September 2017

Evolution of gastro-oesophageal reflux disease over 5 years under routine medical care--the ProGERD study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4436697

28 September 2017

The incidence of oesophageal adenocarcinoma in non-dysplastic Barrett's oesophagus: a meta-analysis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4436697

28 September 2017

Incidence of adenocarcinoma among patients with Barrett's esophagus

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4436697

28 September 2017

Novel probe-based confocal laser endomicroscopy criteria and interobserver agreement for the detection of dysplasia in Barrett's esophagus.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4436697

28 September 2017

Buried metaplasia after endoscopic ablation of Barrett's esophagus: a systematic review

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4436697

28 September 2017

Risk of malignant progression in Barrett's esophagus patients: results from a large population-based study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4436697

28 September 2017

Increasing incidence of Barrett's oesophagus: a population-based study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4436697

28 September 2017

Epidemiology and natural history of intestinal metaplasia of the gastroesophageal junction and Barrett's esophagus: a population-based study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4436697

28 September 2017

American Gastroenterological Association medical position statement on the management of Barrett's esophagus

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4436697

28 September 2017

American Gastroenterological Association technical review on the management of Barrett's esophagus

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4436697

28 September 2017

Using the Delphi technique to determine which outcomes to measure in clinical trials: recommendations for the future based on a systematic review of existing studies

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4436697

28 September 2017

Interobserver variability in the diagnosis of crypt dysplasia in Barrett esophagus

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4436697

28 September 2017

Esophageal adenocarcinoma incidence in individuals with gastroesophageal reflux: synthesis and estimates from population studies.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4436697

28 September 2017

Diagnosis and management of Barrett's oesophagus

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4436697

28 September 2017

Long-term follow-up after anti-reflux surgery in patients with Barrett's esophagus

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4436697

28 September 2017

Interobserver reliability in the endoscopic diagnosis and grading of Barrett's esophagus: an Asian multinational study.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4436697

28 September 2017

Meta-analyses of the effect of symptoms of gastroesophageal reflux on the risk of Barrett's esophagus

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4436697

28 September 2017

Low-grade dysplasia in Barrett's esophagus: overdiagnosed and underestimated

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4436697

28 September 2017

Barrett's surveillance identifies patients with early esophageal adenocarcinoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4436697

28 September 2017

Prevalence and predictors of recurrent neoplasia after ablation of Barrett's esophagus

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4436697

28 September 2017

Risk of esophageal adenocarcinoma and mortality in patients with Barrett's esophagus: a systematic review and meta-analysis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4436697

28 September 2017

Definition of Barrett's esophagus: time for a rethink--is intestinal metaplasia dead?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4436697

28 September 2017

DNA promoter hypermethylation of p16 and APC predicts neoplastic progression in Barrett's esophagus

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4436697

28 September 2017

Medication usage and the risk of neoplasia in patients with Barrett's esophagus

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4436697

28 September 2017

Intestinal differentiation in metaplastic, nongoblet columnar epithelium in the esophagus

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4436697

28 September 2017

Adherence to biopsy guidelines for Barrett's esophagus surveillance in the community setting in the United States

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4436697

28 September 2017

Chemoprevention of oesophageal cancer and the AspECT trial.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4436697

28 September 2017

Quality of Barrett's surveillance in The Netherlands: a standardized review of endoscopy and pathology reports

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4436697

28 September 2017

The incidence of esophageal cancer and high-grade dysplasia in Barrett's esophagus: a systematic review and meta-analysis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4436697

28 September 2017

A systematic review and meta-analysis of the treatment for Barrett's esophagus

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4436697

28 September 2017

Three-tiered risk stratification model to predict progression in Barrett's esophagus using epigenetic and clinical features

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4436697

28 September 2017

Systematic four-quadrant biopsy detects Barrett's dysplasia in more patients than nonsystematic biopsy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4436697

28 September 2017

Effect of proton pump inhibitors on markers of risk for high-grade dysplasia and oesophageal cancer in Barrett's oesophagus

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4436697

28 September 2017

The effect of antireflux surgery on esophageal carcinogenesis in patients with barrett esophagus: a systematic review.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4436697

28 September 2017

Barrett's oesophagus: long-term follow-up after complete ablation with argon plasma coagulation and the factors that determine its recurrence

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4436697

28 September 2017

Colonoscopic withdrawal times and adenoma detection during screening colonoscopy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4436697

28 September 2017

Ablation of nonneoplastic Barrett's mucosa using argon plasma coagulation with concomitant esomeprazole therapy (APBANEX): a prospective multicenter evaluation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4436697

28 September 2017

Surveillance of Barrett's oesophagus: exploring the uncertainty through systematic review, expert workshop and economic modelling

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4436697

28 September 2017

Prevalence of Barrett's esophagus in the general population: an endoscopic study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4436697

28 September 2017

Update on the paris classification of superficial neoplastic lesions in the digestive tract

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4436697

28 September 2017

Prognostic influence of Barrett's oesophagus and Helicobacter pylori infection on healing of erosive gastro-oesophageal reflux disease (GORD) and symptom resolution in non-erosive GORD: report from the ProGORD study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4436697

28 September 2017

Long-term follow-up after complete ablation of Barrett's esophagus with argon plasma coagulation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4436697

28 September 2017

A critical review of the diagnosis and management of Barrett's esophagus: the AGA Chicago Workshop.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4436697

28 September 2017

Long-term clinical and pathologic response of Barrett's esophagus after antireflux surgery.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4436697

28 September 2017

Characterisation of p53 status at the gene, chromosomal and protein levels in oesophageal adenocarcinoma.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4436697

28 September 2017

Mortality in Barrett's oesophagus: results from a population based study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4436697

28 September 2017

The Delphi technique: myths and realities

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4436697

28 September 2017

Preventing death of Barrett's cancer: does frequent surveillance endoscopy do it?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4436697

28 September 2017

Long-term outcome of antireflux surgery in patients with Barrett's esophagus

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4436697

28 September 2017

Reproducibility of the diagnosis of dysplasia in Barrett esophagus: a reaffirmation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4436697

28 September 2017

Final results from 10 year cohort of patients undergoing surveillance for Barrett's oesophagus: observational study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4436697

28 September 2017

p53 abnormalities in adenocarcinoma of the gastric cardia and antrum

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4436697

28 September 2017

Specialized intestinal metaplasia, dysplasia, and cancer of the esophagus and esophagogastric junction: prevalence and clinical data

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4436697

28 September 2017

The effect of four interventions on the informational content of histopathology reports of resected colorectal carcinomas

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4436697

28 September 2017

Barrett's esophagus, dysplasia, and adenocarcinoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4436697

28 September 2017

Length of Barrett's oesophagus: an important factor in the development of dysplasia and adenocarcinoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4436697

28 September 2017

Surveillance in patients with long-segment Barrett's oesophagus: a cost-effectiveness analysis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4436697

2 June 2018

A multicenter, double-blinded validation study of methylation biomarkers for progression prediction in Barrett's esophagus

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4436697

2 June 2018

Crypt dysplasia with surface maturation: a clinical, pathologic, and molecular study of a Barrett's esophagus cohort.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4436697

2 June 2018

Role of p53 gene mutations in human esophageal carcinogenesis: results from immunohistochemical and mutation analyses of carcinomas and nearby non-cancerous lesions

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4436697

2 June 2018

Anti-p53 antibodies in patients with Barrett's esophagus or esophageal carcinoma can predate cancer diagnosis.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4436697

2 June 2018

Improving surveillance for Barrett's oesophagus: AspECT and BOSS trials provide an evidence base

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2015.55

21 January 2018

Detection of intestinal metaplasia in Barrett's esophagus: an observational comparator study suggests the need for a minimum of eight biopsies.

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2015.55

21 January 2018

Ethnicity, gender, and socioeconomic status as risk factors for esophagitis and Barrett's esophagus

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2015.55

21 January 2018

Oesophageal adenocarcinoma and prior diagnosis of Barrett's oesophagus: a population-based study.

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2015.55

21 January 2018

Predictors for neoplastic progression in patients with Barrett's Esophagus: a prospective cohort study

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2015.55

21 January 2018

Editorial: One small step for metaplasia, but one giant leap for biomarkers is needed.

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2015.55

21 January 2018

Epidermal growth factor receptor (EGFR) is overexpressed in high-grade dysplasia and adenocarcinoma of the esophagus and may represent a biomarker of histological progression in Barrett's esophagus (BE).

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2015.55

21 January 2018

Improving the efficiency of Barrett's esophagus management: do biomarkers hit the mark?

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2015.55

21 January 2018

Effects of dropping the requirement for goblet cells from the diagnosis of Barrett's esophagus.

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2015.55

21 January 2018

Prevalence and predictors of columnar lined esophagus in gastroesophageal reflux disease (GERD) patients undergoing upper endoscopy.

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2015.55

21 January 2018

Barrett's dysplasia and the Vienna classification: reproducibility, prediction of progression and impact of consensus reporting and p53 immunohistochemistry.

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2015.55

21 January 2018

Computerized morphometry as an aid in determining the grade of dysplasia and progression to adenocarcinoma in Barrett's esophagus.

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2015.55

21 January 2018

Risk factors for progression of low-grade dysplasia in patients with Barrett's esophagus.

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2015.55

21 January 2018

Comparing virtual with conventional microscopy for the consensus diagnosis of Barrett's neoplasia in the AspECT Barrett's chemoprevention trial pathology audit.

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2015.55

21 January 2018

Grading of dysplasia in Barrett's oesophagus: substantial interobserver variation between general and gastrointestinal pathologists.

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2015.55

21 January 2018

A study of indefinite for dysplasia in Barrett's oesophagus: reproducibility of diagnosis, clinical outcomes and predicting progression with AMACR (alpha-methylacyl-CoA-racemase).

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2015.55

21 January 2018

The Veneto Region's Barrett's Oesophagus Registry: aims, methods, preliminary results.

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2015.55

21 January 2018

Risk factors in the development of esophageal adenocarcinoma

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2015.55

21 January 2018

Waist-to-hip ratio, weight gain, and dietary and serum selenium are associated with DNA content flow cytometry in Barrett's esophagus.

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2015.55

21 January 2018

Clinical and endoscopic factors predict higher pathologic grades of Barrett dysplasia

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2015.55

21 January 2018

Validation of the Prague C&M classification of Barrett's esophagus in clinical practice.

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2015.55

21 January 2018

The application of Prague C and M criteria in the diagnosis of Barrett's esophagus in an ethnic Chinese population

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2015.55

21 January 2018

Management of Barrett's esophagus in the UK: overtreated and underbiopsied but improved by the introduction of a national randomized trial.

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2015.55

21 January 2018

A population-based, retrospective, cohort study of esophageal cancer missed at endoscopy.

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2015.55

21 January 2018

Prospective evaluation of the macroscopic types and location of early Barrett's neoplasia in 380 lesions.

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2015.55

21 January 2018

Surveillance and survival in Barrett's adenocarcinomas: a population-based study

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2015.55

21 January 2018

Cause-specific mortality of people with Barrett's esophagus compared with the general population: a population-based cohort study.

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2015.55

21 January 2018

Low incidence of adenocarcinoma and high-grade intraepithelial neoplasia in patients with Barrett's esophagus: a prospective cohort study.

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2015.55

21 January 2018

Long-term endoscopic surveillance of patients with Barrett's esophagus. incidence of dysplasia and adenocarcinoma: a prospective study

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2015.55

21 January 2018

Mortality rates in patients with Barrett's oesophagus.

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2015.55

21 January 2018

Risk of mortality and cancer incidence in Barrett's esophagus.

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2015.55

21 January 2018

Mortality in Barrett's esophagus: three decades of experience at a single center.

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2015.55

21 January 2018

A Barrett's esophagus registry of over 1000 patients from a specialist center highlights greater risk of progression than population-based registries and high risk of low grade dysplasia.

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2015.55

21 January 2018

Risk stratification of patients with barrett's esophagus and low-grade dysplasia or indefinite for dysplasia.

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2015.55

21 January 2018

Patients with nondysplastic Barrett's esophagus have low risks for developing dysplasia or esophageal adenocarcinoma.

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2015.55

21 January 2018

Long-term efficacy and safety of endoscopic resection for patients with mucosal adenocarcinoma of the esophagus

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2015.55

21 January 2018

Aneuploidy and Overexpression of Ki67 and p53 as Markers for Neoplastic Progression in Barrett's Esophagus: A Case–Control Study

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2015.55

21 January 2018

Aberrant p53 protein expression is associated with an increased risk of neoplastic progression in patients with Barrett's oesophagus

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2015.55

21 January 2018

Proton pump inhibitors are associated with reduced incidence of dysplasia in Barrett's esophagus

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2015.55

21 January 2018

Use of Proton Pump Inhibitors and Risk of Progression of Barrett's Esophagus to Neoplastic Lesions

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2015.55

21 January 2018

Medical or surgical management of GERD patients with Barrett's esophagus: the LOTUS trial 3-year experience

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2015.55

21 January 2018

Barrett’s Esophagus Can and Does Regress After Antireflux Surgery: A Study of Prevalence and Predictive Features

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2015.55

21 January 2018

Long-term results of a randomized prospective study comparing medical and surgical treatment of Barrett's esophagus

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2015.55

21 January 2018

Long-term outcome of medical and surgical therapies for gastroesophageal reflux disease: follow-up of a randomized controlled trial.

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2015.55

21 January 2018

The risk of esophageal adenocarcinoma after antireflux surgery.

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2015.55

21 January 2018

The Development and Validation of an Endoscopic Grading System for Barrett’s Esophagus: The Prague C & M Criteria

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2015.55

21 January 2018

Acetic acid chromoendoscopy in Barrett's esophagus surveillance is superior to the standardized random biopsy protocol: results from a large cohort study (with video)

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2015.55

21 January 2018

Symptomatic Gastroesophageal Reflux as a Risk Factor for Esophageal Adenocarcinoma

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2015.55

21 January 2018

Mortality Associated with Barrett's Esophagus and Gastroesophageal Reflux Disease Diagnoses-A Population-Based Cohort Study

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2015.55

21 January 2018

Does a surgical antireflux procedure decrease the incidence of esophageal adenocarcinoma in Barrett's esophagus? A meta-analysis.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4436697

27 November 2018

Nonsteroidal anti-inflammatory drug use, body mass index, and anthropometry in relation to genetic and flow cytometric abnormalities in Barrett's esophagus.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4436697

27 November 2018

Acid suppression therapy may not alter malignant progression in Barrett's metaplasia showing p53 protein accumulation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4436697

27 November 2018

p53 is frequently mutated in Barrett's metaplasia of the intestinal type.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4436697

27 November 2018

Yield of intestinal metaplasia in patients with suspected short-segment Barrett's esophagus (SSBE) on repeat endoscopy

1 reference

https://pubmed.ncbi.nlm.nih.gov/25869390

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Rigorous surveillance protocol increases detection of curable cancers associated with Barrett's esophagus

1 reference

https://pubmed.ncbi.nlm.nih.gov/25869390

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Endoscopic mucosal resection of early cancer and high-grade dysplasia in Barrett's esophagus

1 reference

https://pubmed.ncbi.nlm.nih.gov/25869390

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Current United Kingdom practice in the diagnosis and management of columnar-lined oesophagus: results of the United Kingdom National Barrett's Oesophagus Registry endoscopist questionnaire

1 reference

https://pubmed.ncbi.nlm.nih.gov/25869390

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Surveillance history of endoscopically treated patients with early Barrett's neoplasia: nonadherence to the Seattle biopsy protocol leads to sampling error

1 reference

https://pubmed.ncbi.nlm.nih.gov/25869390

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Missed diagnoses in patients with upper gastrointestinal cancers

1 reference

https://pubmed.ncbi.nlm.nih.gov/25869390

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Risk factors for the development of an adenocarcinoma in columnar-lined (Barrett) esophagus. The Rotterdam Esophageal Tumor Study Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/25869390

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Long-Term Follow-up of Barrett’s Epithelium: Medical Versus Antireflux Surgical Therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/25869390

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Randomized crossover study comparing efficacy of transnasal endoscopy with that of standard endoscopy to detect Barrett's esophagus

1 reference

https://pubmed.ncbi.nlm.nih.gov/25869390

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The significance of "indefinite for dysplasia" grading in Barrett metaplasia

1 reference

https://pubmed.ncbi.nlm.nih.gov/25869390

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pyloric gland adenoma arising in Barrett's esophagus with mucin immunohistochemical and molecular cytogenetic evaluation

1 reference

https://pubmed.ncbi.nlm.nih.gov/25869390

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The cost-effectiveness of biomarkers for predicting the development of oesophageal adenocarcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/25869390

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Barrett's surveillance is worthwhile and detects curable cancers. A prospective cohort study addressing cancer incidence, treatment outcome and survival

1 reference

https://pubmed.ncbi.nlm.nih.gov/25869390

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Barrett's esophagus specialist clinic: what difference can it make?

1 reference

https://pubmed.ncbi.nlm.nih.gov/25869390

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

p53 gene mutation and protein accumulation during neoplastic progression in Barrett's esophagus

1 reference

https://pubmed.ncbi.nlm.nih.gov/25869390

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Life expectancy and cancer risk in patients with Barrett's esophagus: a prospective controlled investigation

1 reference

https://pubmed.ncbi.nlm.nih.gov/25869390

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Histologic evaluation of resection specimens obtained at 293 endoscopic resections in Barrett's esophagus

1 reference

https://pubmed.ncbi.nlm.nih.gov/25869390

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Proton pump inhibitors reduce cell cycle abnormalities in Barrett's esophagus

1 reference

https://pubmed.ncbi.nlm.nih.gov/25869390

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Dysplasia detection rate of confirmatory EGD in nondysplastic Barrett's esophagus

1 reference

https://pubmed.ncbi.nlm.nih.gov/25869390

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Risk for esophageal neoplasia in Barrett's esophagus patients with mucosal changes indefinite for dysplasia

1 reference

https://pubmed.ncbi.nlm.nih.gov/25869390

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Extent of low-grade dysplasia is a risk factor for the development of esophageal adenocarcinoma in Barrett's esophagus

1 reference

https://pubmed.ncbi.nlm.nih.gov/25869390

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cost Utility of Screening for Barrett’s Esophagus With Esophageal Capsule Endoscopy Versus Conventional Upper Endoscopy

1 reference

https://pubmed.ncbi.nlm.nih.gov/25869390

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Two distinct pathways of tumorigenesis of adenocarcinomas of the esophagogastric junction, related or unrelated to intestinal metaplasia

1 reference

https://pubmed.ncbi.nlm.nih.gov/25869390

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Safety of a systematic endoscopic biopsy protocol in patients with Barrett's esophagus

1 reference

https://pubmed.ncbi.nlm.nih.gov/25869390

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The diagnosis of low-grade dysplasia in Barrett's esophagus and its implications for disease progression

1 reference

https://pubmed.ncbi.nlm.nih.gov/25869390

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prospective, controlled tandem endoscopy study of narrow band imaging for dysplasia detection in Barrett's Esophagus

1 reference

https://pubmed.ncbi.nlm.nih.gov/25869390

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Erosive esophagitis is a risk factor for Barrett's esophagus: a community-based endoscopic follow-up study

1 reference

https://pubmed.ncbi.nlm.nih.gov/25869390

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Grading of gastric foveolar-type dysplasia in Barrett's esophagus

1 reference

https://pubmed.ncbi.nlm.nih.gov/25869390

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1038/AJG.2015.55

1 reference

Europe PubMed Central

25 June 2017

OpenCitations bibliographic resource ID

1 reference

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

1 reference

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

1 reference

Europe PubMed Central

25 June 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q27332349&oldid=1845123190"